Conferences - Results from #380

EAU 2023: Burning Questions in Oncological Urology: How to Integrate Metastasis-Directed and Systemic Treatment in Patients with Oligometastatic Renal Cell Carcinoma March 11, 2023

EAU 2023: State-of-the-Art Lecture: Immunotherapy in Locally Advanced and Metastatic UTUC: A Reality? March 11, 2023

EAU 2023: State-of-the-Art Lecture: Improvement in Technologies and Drugs to Support Kidney Sparing Surgery March 11, 2023

EAU 2023: Discussant: 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma - Results from Phase 3 ZIRCON Study March 11, 2023

EAU 2023: State-of-the-Art Lecture: Role of Systemic Chemotherapy After Radical Nephroureterectomy March 11, 2023

EAU 2023: Impact of Pre-operative PSMA PET/CT for Men with cN0M0 Conventional Imaging and pN+ Prostate Cancer: Results from a Multicenter Study March 11, 2023

EAU 2023: 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma - Results from Phase 3 ZIRCON Study March 11, 2023

Urine Gene Test Can Predict Bladder Cancer Years Before Diagnosis March 11, 2023

Male or Female Urologist? Depends How Much It Hurts, Research Shows March 11, 2023

EAU 2023: PSMA PET for High Risk Prostate Cancer: A Cost Effective Strategy March 11, 2023

EAU 2023: Prospective Evaluation of the Diagnostic Accuracy of Different PSMA PET/CT Tracers for the Nodal Staging of Radical Prostatectomy Candidates: A Single Institutional Analysis March 11, 2023

EAU 2023: Artificial Intelligence to Improve Cancer Detection in Transperineal MRI/ultrasound Fusion Biopsies of the Prostate – a Prospective Evaluation March 11, 2023

EAU 2023: The Prognostic Impact of Preoperative PSMA-PET on Early Oncological Outcomes in Prostate Cancer Patients Treated with Radical Prostatectomy: Results of a Multi-Center Analysis March 11, 2023

EAU 2023: State-of-the-Art Lecture: Psycho-oncological Counselling of Locally Advanced Bladder Cancer March 11, 2023

EAU 2023: Discussant: A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle Invasive Bladder Cancer (NMIBC) March 11, 2023

EAU 2023: How Should Lesions Without Anatomical Correspondence in 18F-PSMA-1007 PET/CT Be Interpreted - a PROSTAGE Follow-up Study March 11, 2023

EAU 2023: Exploring the Effect of Metastasis Directed Therapy on Progression Patterns of Patients with Positive 68Ga-PSMA PET/CT and Biochemical Recurrence from Prostate Cancer March 11, 2023

EAU 2023: PSMA-PET for Recurrent Prostate Cancer and Guidance of Salvage Treatments: Is the Sooner Always the Better? (“Shoot Blind” or “Sharpshooting”?) March 11, 2023

EAU 2023: Validation of 18F-DCFPyL PET Radiomics-Based Machine Learning Models in Intermediate- to High-Risk Primary Prostate Cancer March 11, 2023

EAU 2023: Survival after Radical Prostatectomy vs. Radiation Therapy in Clinical Node Positive Prostate Cancer Patients: A Multicentric Study March 11, 2023

Page 20 of 522